nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—Salicylic acid—Mesalazine—Crohn's disease	0.44	1	CrCrCtD
Niacin—SLC22A5—Crohn's disease	0.407	1	CbGaD
Niacin—NNMT—gall bladder—Crohn's disease	0.00437	0.15	CbGeAlD
Niacin—HCAR2—skin of body—Crohn's disease	0.00382	0.131	CbGeAlD
Niacin—HCAR2—lymphoid tissue—Crohn's disease	0.0031	0.106	CbGeAlD
Niacin—NNMT—smooth muscle tissue—Crohn's disease	0.00218	0.0746	CbGeAlD
Niacin—NNMT—mammalian vulva—Crohn's disease	0.00196	0.0672	CbGeAlD
Niacin—HCAR2—lymph node—Crohn's disease	0.00175	0.0598	CbGeAlD
Niacin—NNMT—digestive system—Crohn's disease	0.00172	0.0589	CbGeAlD
Niacin—Skin hyperpigmentation—Mercaptopurine—Crohn's disease	0.00155	0.0248	CcSEcCtD
Niacin—SLC16A3—epithelium—Crohn's disease	0.00154	0.0529	CbGeAlD
Niacin—SLC16A3—smooth muscle tissue—Crohn's disease	0.00149	0.051	CbGeAlD
Niacin—Glucose tolerance decreased—Prednisone—Crohn's disease	0.00132	0.0211	CcSEcCtD
Niacin—Cholestasis—Mercaptopurine—Crohn's disease	0.00122	0.0194	CcSEcCtD
Niacin—Hepatotoxicity—Mercaptopurine—Crohn's disease	0.0012	0.0191	CcSEcCtD
Niacin—Prostatic disorder—Mesalazine—Crohn's disease	0.00118	0.0189	CcSEcCtD
Niacin—SLC16A3—digestive system—Crohn's disease	0.00118	0.0402	CbGeAlD
Niacin—Hyperuricaemia—Mercaptopurine—Crohn's disease	0.000997	0.0159	CcSEcCtD
Niacin—Faecal incontinence—Mesalazine—Crohn's disease	0.000994	0.0159	CcSEcCtD
Niacin—NNMT—lymph node—Crohn's disease	0.000983	0.0336	CbGeAlD
Niacin—Blood uric acid increased—Mercaptopurine—Crohn's disease	0.000941	0.015	CcSEcCtD
Niacin—SLC16A1—epithelium—Crohn's disease	0.000938	0.0321	CbGeAlD
Niacin—Tongue oedema—Mesalazine—Crohn's disease	0.000895	0.0143	CcSEcCtD
Niacin—Gastrointestinal symptom NOS—Mesalazine—Crohn's disease	0.000853	0.0136	CcSEcCtD
Niacin—NNMT—Metapathway biotransformation—GPX4—Crohn's disease	0.000846	0.0139	CbGpPWpGaD
Niacin—SLC5A8—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000845	0.0139	CbGpPWpGaD
Niacin—SLC5A8—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000845	0.0139	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.000835	0.0137	CbGpPWpGaD
Niacin—Enlargement abdomen—Mesalazine—Crohn's disease	0.000834	0.0133	CcSEcCtD
Niacin—Cholelithiasis—Mesalazine—Crohn's disease	0.000807	0.0129	CcSEcCtD
Niacin—HCAR2—G alpha (i) signalling events—CCR9—Crohn's disease	0.000768	0.0126	CbGpPWpGaD
Niacin—Herpes zoster—Azathioprine—Crohn's disease	0.000731	0.0117	CcSEcCtD
Niacin—HCAR3—G alpha (i) signalling events—CCR9—Crohn's disease	0.000728	0.012	CbGpPWpGaD
Niacin—Cholestasis—Azathioprine—Crohn's disease	0.000725	0.0116	CcSEcCtD
Niacin—Burning sensation—Mesalazine—Crohn's disease	0.000722	0.0115	CcSEcCtD
Niacin—SLC16A1—digestive system—Crohn's disease	0.000714	0.0244	CbGeAlD
Niacin—Hepatotoxicity—Azathioprine—Crohn's disease	0.000713	0.0114	CcSEcCtD
Niacin—Lung disorder—Mesalazine—Crohn's disease	0.000709	0.0113	CcSEcCtD
Niacin—HCAR2—GPCR ligand binding—ACKR2—Crohn's disease	0.000707	0.0116	CbGpPWpGaD
Niacin—SLCO2B1—Transport of organic anions—ALB—Crohn's disease	0.000706	0.0116	CbGpPWpGaD
Niacin—Tongue disorder—Mesalazine—Crohn's disease	0.00069	0.011	CcSEcCtD
Niacin—HCAR3—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.000675	0.0111	CbGpPWpGaD
Niacin—SLC16A3—lymph node—Crohn's disease	0.000671	0.023	CbGeAlD
Niacin—HCAR3—GPCR ligand binding—ACKR2—Crohn's disease	0.000671	0.011	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—MLN—Crohn's disease	0.000671	0.011	CbGpPWpGaD
Niacin—Cholestasis—Mesalazine—Crohn's disease	0.000661	0.0106	CcSEcCtD
Niacin—Hepatotoxicity—Mesalazine—Crohn's disease	0.00065	0.0104	CcSEcCtD
Niacin—Amblyopia—Mesalazine—Crohn's disease	0.00065	0.0104	CcSEcCtD
Niacin—Feeling hot—Mesalazine—Crohn's disease	0.000639	0.0102	CcSEcCtD
Niacin—HCAR3—GPCR ligand binding—MLN—Crohn's disease	0.000636	0.0105	CbGpPWpGaD
Niacin—Rash pustular—Mesalazine—Crohn's disease	0.000629	0.0101	CcSEcCtD
Niacin—HCAR3—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.000628	0.0103	CbGpPWpGaD
Niacin—Jaundice cholestatic—Azathioprine—Crohn's disease	0.000627	0.01	CcSEcCtD
Niacin—SLCO2B1—digestive system—Crohn's disease	0.000614	0.021	CbGeAlD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00061	0.01	CbGpPWpGaD
Niacin—SLC5A8—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000595	0.00979	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000579	0.00952	CbGpPWpGaD
Niacin—Breast pain—Mesalazine—Crohn's disease	0.000575	0.00919	CcSEcCtD
Niacin—Jaundice cholestatic—Mesalazine—Crohn's disease	0.000571	0.00912	CcSEcCtD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000567	0.00933	CbGpPWpGaD
Niacin—SLC16A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000566	0.0093	CbGpPWpGaD
Niacin—Skin discolouration—Mesalazine—Crohn's disease	0.000555	0.00887	CcSEcCtD
Niacin—Bone disorder—Mesalazine—Crohn's disease	0.000555	0.00887	CcSEcCtD
Niacin—Cough increased—Mesalazine—Crohn's disease	0.000548	0.00876	CcSEcCtD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000538	0.00885	CbGpPWpGaD
Niacin—Gout—Mesalazine—Crohn's disease	0.000537	0.00858	CcSEcCtD
Niacin—SLC5A8—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000526	0.00865	CbGpPWpGaD
Niacin—SLC22A5—skin of body—Crohn's disease	0.00051	0.0175	CbGeAlD
Niacin—HCAR2—G alpha (i) signalling events—CCR6—Crohn's disease	0.000509	0.00836	CbGpPWpGaD
Niacin—Stomatitis—Mercaptopurine—Crohn's disease	0.000504	0.00805	CcSEcCtD
Niacin—Vaginal inflammation—Mesalazine—Crohn's disease	0.000502	0.00802	CcSEcCtD
Niacin—Eructation—Mesalazine—Crohn's disease	0.000493	0.00788	CcSEcCtD
Niacin—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.00049	0.00806	CbGpPWpGaD
Niacin—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.00049	0.00806	CbGpPWpGaD
Niacin—HCAR3—G alpha (i) signalling events—CCR6—Crohn's disease	0.000482	0.00793	CbGpPWpGaD
Niacin—Skin exfoliation—Mesalazine—Crohn's disease	0.000479	0.00765	CcSEcCtD
Niacin—Vaginal infection—Mesalazine—Crohn's disease	0.000474	0.00757	CcSEcCtD
Niacin—HCAR2—GPCR ligand binding—CCR9—Crohn's disease	0.000465	0.00764	CbGpPWpGaD
Niacin—Cramps of lower extremities—Mesalazine—Crohn's disease	0.000461	0.00736	CcSEcCtD
Niacin—Hepatic function abnormal—Azathioprine—Crohn's disease	0.000458	0.00731	CcSEcCtD
Niacin—HCAR3—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000447	0.00736	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—CCR9—Crohn's disease	0.000441	0.00725	CbGpPWpGaD
Niacin—Hypertonia—Mesalazine—Crohn's disease	0.00044	0.00703	CcSEcCtD
Niacin—HCAR2—GPCR ligand binding—GPR65—Crohn's disease	0.000432	0.00711	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000429	0.00706	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000429	0.00706	CbGpPWpGaD
Niacin—QPRT—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Crohn's disease	0.000428	0.00704	CbGpPWpGaD
Niacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000422	0.00693	CbGpPWpGaD
Niacin—Hypothyroidism—Prednisone—Crohn's disease	0.000414	0.00661	CcSEcCtD
Niacin—SLC16A3—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000413	0.00679	CbGpPWpGaD
Niacin—SLC16A3—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000413	0.00679	CbGpPWpGaD
Niacin—Alopecia—Mercaptopurine—Crohn's disease	0.00041	0.00655	CcSEcCtD
Niacin—HCAR3—GPCR ligand binding—GPR65—Crohn's disease	0.00041	0.00674	CbGpPWpGaD
Niacin—SLC22A5—digestive system—Crohn's disease	0.000408	0.014	CbGeAlD
Niacin—SLC16A1—lymph node—Crohn's disease	0.000408	0.014	CbGeAlD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—ITGA4—Crohn's disease	0.000406	0.00667	CbGpPWpGaD
Niacin—Eczema—Mesalazine—Crohn's disease	0.000405	0.00647	CcSEcCtD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000404	0.00665	CbGpPWpGaD
Niacin—Malnutrition—Mercaptopurine—Crohn's disease	0.000404	0.00646	CcSEcCtD
Niacin—Peptic ulcer—Prednisone—Crohn's disease	0.000397	0.00634	CcSEcCtD
Niacin—HCAR3—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000394	0.00648	CbGpPWpGaD
Niacin—Atrial fibrillation—Mesalazine—Crohn's disease	0.000384	0.00614	CcSEcCtD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000383	0.0063	CbGpPWpGaD
Niacin—Dermatitis bullous—Mesalazine—Crohn's disease	0.000381	0.00609	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—MLN—Crohn's disease	0.000379	0.00623	CbGpPWpGaD
Niacin—Myopathy—Prednisone—Crohn's disease	0.000379	0.00605	CcSEcCtD
Niacin—Hepatomegaly—Prednisone—Crohn's disease	0.000375	0.00599	CcSEcCtD
Niacin—Arthritis—Mesalazine—Crohn's disease	0.000375	0.00599	CcSEcCtD
Niacin—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.000364	0.00582	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—ACKR2—Crohn's disease	0.000363	0.00597	CbGpPWpGaD
Niacin—Leukopenia—Mercaptopurine—Crohn's disease	0.000362	0.00578	CcSEcCtD
Niacin—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.000361	0.00577	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—MLN—Crohn's disease	0.000359	0.00591	CbGpPWpGaD
Niacin—Migraine—Mesalazine—Crohn's disease	0.000358	0.00573	CcSEcCtD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000356	0.00585	CbGpPWpGaD
Niacin—Glaucoma—Prednisone—Crohn's disease	0.000353	0.00563	CcSEcCtD
Niacin—Face oedema—Mesalazine—Crohn's disease	0.000352	0.00562	CcSEcCtD
Niacin—SLCO2B1—lymph node—Crohn's disease	0.000351	0.012	CbGeAlD
Niacin—HCAR3—Signaling by GPCR—ACKR2—Crohn's disease	0.000344	0.00566	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—MLN—Crohn's disease	0.000344	0.00566	CbGpPWpGaD
Niacin—Arthralgia—Mercaptopurine—Crohn's disease	0.000344	0.0055	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000342	0.00546	CcSEcCtD
Niacin—Necrosis—Prednisone—Crohn's disease	0.000338	0.0054	CcSEcCtD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000337	0.00555	CbGpPWpGaD
Niacin—Liver function test abnormal—Mesalazine—Crohn's disease	0.000336	0.00537	CcSEcCtD
Niacin—Dry skin—Mesalazine—Crohn's disease	0.000334	0.00533	CcSEcCtD
Niacin—Orthostatic hypotension—Mesalazine—Crohn's disease	0.000333	0.00531	CcSEcCtD
Niacin—Oedema—Mercaptopurine—Crohn's disease	0.00033	0.00527	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—MLN—Crohn's disease	0.000326	0.00537	CbGpPWpGaD
Niacin—Skin disorder—Mercaptopurine—Crohn's disease	0.00032	0.00512	CcSEcCtD
Niacin—Abdominal distension—Mesalazine—Crohn's disease	0.000317	0.00506	CcSEcCtD
Niacin—Dysphagia—Mesalazine—Crohn's disease	0.000315	0.00503	CcSEcCtD
Niacin—Influenza—Mesalazine—Crohn's disease	0.000315	0.00503	CcSEcCtD
Niacin—Anorexia—Mercaptopurine—Crohn's disease	0.000314	0.00502	CcSEcCtD
Niacin—HCAR2—GPCR ligand binding—CCR6—Crohn's disease	0.000308	0.00506	CbGpPWpGaD
Niacin—Angina pectoris—Mesalazine—Crohn's disease	0.000307	0.0049	CcSEcCtD
Niacin—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000305	0.00502	CbGpPWpGaD
Niacin—Bronchitis—Mesalazine—Crohn's disease	0.000303	0.00484	CcSEcCtD
Niacin—SLC5A8—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000302	0.00497	CbGpPWpGaD
Niacin—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.0003	0.0048	CcSEcCtD
Niacin—HCAR3—GPCR ligand binding—CCR6—Crohn's disease	0.000292	0.0048	CbGpPWpGaD
Niacin—SLC16A3—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000291	0.00478	CbGpPWpGaD
Niacin—Decreased appetite—Mercaptopurine—Crohn's disease	0.000287	0.00458	CcSEcCtD
Niacin—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000285	0.00455	CcSEcCtD
Niacin—Haemoglobin—Azathioprine—Crohn's disease	0.000278	0.00444	CcSEcCtD
Niacin—Haemorrhage—Azathioprine—Crohn's disease	0.000277	0.00442	CcSEcCtD
Niacin—Stomatitis—Mesalazine—Crohn's disease	0.000274	0.00437	CcSEcCtD
Niacin—Jaundice—Mesalazine—Crohn's disease	0.000274	0.00437	CcSEcCtD
Niacin—HCAR2—GPCR ligand binding—PTGER4—Crohn's disease	0.000271	0.00446	CbGpPWpGaD
Niacin—Sweating—Mesalazine—Crohn's disease	0.000269	0.0043	CcSEcCtD
Niacin—SLC5A8—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000267	0.0044	CbGpPWpGaD
Niacin—QPRT—Disease—RSPO3—Crohn's disease	0.000266	0.00437	CbGpPWpGaD
Niacin—CYP2D6—digestive system—Crohn's disease	0.000263	0.00901	CbGeAlD
Niacin—HCAR2—GPCR downstream signaling—CCR9—Crohn's disease	0.000263	0.00432	CbGpPWpGaD
Niacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000263	0.00432	CbGpPWpGaD
Niacin—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	0.000262	0.00431	CbGpPWpGaD
Niacin—Body temperature increased—Mercaptopurine—Crohn's disease	0.000261	0.00417	CcSEcCtD
Niacin—SLC16A3—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000257	0.00423	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—PTGER4—Crohn's disease	0.000257	0.00423	CbGpPWpGaD
Niacin—QPRT—Metabolism—PLA2G4F—Crohn's disease	0.000254	0.00418	CbGpPWpGaD
Niacin—Skin exfoliation—Prednisone—Crohn's disease	0.000253	0.00405	CcSEcCtD
Niacin—Haemoglobin—Mesalazine—Crohn's disease	0.000253	0.00405	CcSEcCtD
Niacin—Rhinitis—Mesalazine—Crohn's disease	0.000253	0.00404	CcSEcCtD
Niacin—Fluid retention—Prednisone—Crohn's disease	0.000252	0.00403	CcSEcCtD
Niacin—Hepatitis—Mesalazine—Crohn's disease	0.000252	0.00403	CcSEcCtD
Niacin—Haemorrhage—Mesalazine—Crohn's disease	0.000252	0.00403	CcSEcCtD
Niacin—QPRT—Disease—SEL1L—Crohn's disease	0.000252	0.00414	CbGpPWpGaD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000251	0.00412	CbGpPWpGaD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000251	0.00412	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—CCR9—Crohn's disease	0.000249	0.0041	CbGpPWpGaD
Niacin—Oedema peripheral—Mesalazine—Crohn's disease	0.000248	0.00397	CcSEcCtD
Niacin—Chills—Azathioprine—Crohn's disease	0.000248	0.00397	CcSEcCtD
Niacin—Arrhythmia—Azathioprine—Crohn's disease	0.000247	0.00395	CcSEcCtD
Niacin—Alopecia—Azathioprine—Crohn's disease	0.000244	0.0039	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—GPR65—Crohn's disease	0.000244	0.00402	CbGpPWpGaD
Niacin—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000243	0.00388	CcSEcCtD
Niacin—Oesophagitis—Prednisone—Crohn's disease	0.000243	0.00388	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—CCR9—Crohn's disease	0.000239	0.00392	CbGpPWpGaD
Niacin—NNMT—Metabolism—PLA2G4F—Crohn's disease	0.000236	0.00389	CbGpPWpGaD
Niacin—Eye disorder—Mesalazine—Crohn's disease	0.000235	0.00376	CcSEcCtD
Niacin—Tinnitus—Mesalazine—Crohn's disease	0.000235	0.00375	CcSEcCtD
Niacin—SLC22A5—lymph node—Crohn's disease	0.000233	0.00798	CbGeAlD
Niacin—HCAR3—GPCR downstream signaling—GPR65—Crohn's disease	0.000231	0.00381	CbGpPWpGaD
Niacin—Angiopathy—Mesalazine—Crohn's disease	0.000229	0.00365	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—CCR9—Crohn's disease	0.000226	0.00372	CbGpPWpGaD
Niacin—Chills—Mesalazine—Crohn's disease	0.000226	0.00361	CcSEcCtD
Niacin—QPRT—Disease—LTF—Crohn's disease	0.000226	0.00371	CbGpPWpGaD
Niacin—Diarrhoea—Mercaptopurine—Crohn's disease	0.000226	0.00361	CcSEcCtD
Niacin—SLC16A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000223	0.00366	CbGpPWpGaD
Niacin—SLC16A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000223	0.00366	CbGpPWpGaD
Niacin—Alopecia—Mesalazine—Crohn's disease	0.000223	0.00356	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—GPR65—Crohn's disease	0.000222	0.00365	CbGpPWpGaD
Niacin—Diabetes mellitus—Prednisone—Crohn's disease	0.000222	0.00354	CcSEcCtD
Niacin—Erythema—Mesalazine—Crohn's disease	0.000219	0.0035	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—ITGA4—Crohn's disease	0.000219	0.0036	CbGpPWpGaD
Niacin—QPRT—Metabolism—MTMR3—Crohn's disease	0.000216	0.00356	CbGpPWpGaD
Niacin—Flatulence—Mesalazine—Crohn's disease	0.000216	0.00345	CcSEcCtD
Niacin—Leukopenia—Azathioprine—Crohn's disease	0.000216	0.00344	CcSEcCtD
Niacin—Tension—Mesalazine—Crohn's disease	0.000215	0.00344	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—ACKR2—Crohn's disease	0.000214	0.00353	CbGpPWpGaD
Niacin—Nervousness—Mesalazine—Crohn's disease	0.000213	0.0034	CcSEcCtD
Niacin—Muscle spasms—Mesalazine—Crohn's disease	0.000211	0.00337	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—GPR65—Crohn's disease	0.00021	0.00346	CbGpPWpGaD
Niacin—Vomiting—Mercaptopurine—Crohn's disease	0.00021	0.00335	CcSEcCtD
Niacin—SLC16A3—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00021	0.00345	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00021	0.00345	CbGpPWpGaD
Niacin—Rash—Mercaptopurine—Crohn's disease	0.000208	0.00332	CcSEcCtD
Niacin—Dermatitis—Mercaptopurine—Crohn's disease	0.000208	0.00332	CcSEcCtD
Niacin—Vision blurred—Mesalazine—Crohn's disease	0.000207	0.0033	CcSEcCtD
Niacin—Myalgia—Azathioprine—Crohn's disease	0.000205	0.00327	CcSEcCtD
Niacin—Arthralgia—Azathioprine—Crohn's disease	0.000205	0.00327	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000204	0.00325	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—MLN—Crohn's disease	0.000203	0.00334	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ACKR2—Crohn's disease	0.000203	0.00334	CbGpPWpGaD
Niacin—NNMT—Metabolism—MTMR3—Crohn's disease	0.000201	0.00331	CbGpPWpGaD
Niacin—Angioedema—Mesalazine—Crohn's disease	0.0002	0.0032	CcSEcCtD
Niacin—Vertigo—Mesalazine—Crohn's disease	0.000197	0.00315	CcSEcCtD
Niacin—Syncope—Mesalazine—Crohn's disease	0.000197	0.00314	CcSEcCtD
Niacin—Leukopenia—Mesalazine—Crohn's disease	0.000196	0.00314	CcSEcCtD
Niacin—Nausea—Mercaptopurine—Crohn's disease	0.000196	0.00313	CcSEcCtD
Niacin—Palpitations—Mesalazine—Crohn's disease	0.000194	0.0031	CcSEcCtD
Niacin—Loss of consciousness—Mesalazine—Crohn's disease	0.000193	0.00308	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—MLN—Crohn's disease	0.000193	0.00317	CbGpPWpGaD
Niacin—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000193	0.00308	CcSEcCtD
Niacin—SLC22A5—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000192	0.00315	CbGpPWpGaD
Niacin—Cough—Mesalazine—Crohn's disease	0.000191	0.00306	CcSEcCtD
Niacin—Skin disorder—Azathioprine—Crohn's disease	0.000191	0.00305	CcSEcCtD
Niacin—SLC5A8—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000189	0.00312	CbGpPWpGaD
Niacin—Arthralgia—Mesalazine—Crohn's disease	0.000187	0.00298	CcSEcCtD
Niacin—Myalgia—Mesalazine—Crohn's disease	0.000187	0.00298	CcSEcCtD
Niacin—Face oedema—Prednisone—Crohn's disease	0.000186	0.00297	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—TAGAP—Crohn's disease	0.000186	0.00306	CbGpPWpGaD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000185	0.00296	CcSEcCtD
Niacin—Hypotension—Azathioprine—Crohn's disease	0.000184	0.00293	CcSEcCtD
Niacin—Dry mouth—Mesalazine—Crohn's disease	0.000183	0.00292	CcSEcCtD
Niacin—QPRT—Disease—GCKR—Crohn's disease	0.000182	0.00299	CbGpPWpGaD
Niacin—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000179	0.00286	CcSEcCtD
Niacin—Oedema—Mesalazine—Crohn's disease	0.000179	0.00286	CcSEcCtD
Niacin—Anaphylactic shock—Mesalazine—Crohn's disease	0.000179	0.00286	CcSEcCtD
Niacin—SLC16A3—Hemostasis—F5—Crohn's disease	0.000179	0.00294	CbGpPWpGaD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000177	0.00291	CbGpPWpGaD
Niacin—Dry skin—Prednisone—Crohn's disease	0.000177	0.00282	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—TAGAP—Crohn's disease	0.000176	0.0029	CbGpPWpGaD
Niacin—Shock—Mesalazine—Crohn's disease	0.000176	0.00281	CcSEcCtD
Niacin—Salicylic acid—PTGS2—Crohn's disease	0.000175	0.529	CrCbGaD
Niacin—Tachycardia—Mesalazine—Crohn's disease	0.000175	0.00279	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—CCR6—Crohn's disease	0.000174	0.00286	CbGpPWpGaD
Niacin—Skin disorder—Mesalazine—Crohn's disease	0.000174	0.00278	CcSEcCtD
Niacin—Hyperhidrosis—Mesalazine—Crohn's disease	0.000173	0.00276	CcSEcCtD
Niacin—Anorexia—Mesalazine—Crohn's disease	0.000171	0.00273	CcSEcCtD
Niacin—Muscular weakness—Prednisone—Crohn's disease	0.00017	0.00272	CcSEcCtD
Niacin—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00017	0.00271	CcSEcCtD
Niacin—QPRT—Metabolism—FADS1—Crohn's disease	0.000169	0.00277	CbGpPWpGaD
Niacin—Abdominal distension—Prednisone—Crohn's disease	0.000168	0.00268	CcSEcCtD
Niacin—Hypotension—Mesalazine—Crohn's disease	0.000167	0.00267	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—CCR6—Crohn's disease	0.000165	0.00271	CbGpPWpGaD
Niacin—HCAR2—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000164	0.00269	CbGpPWpGaD
Niacin—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000163	0.00261	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—RSPO3—Crohn's disease	0.000163	0.00267	CbGpPWpGaD
Niacin—Insomnia—Mesalazine—Crohn's disease	0.000162	0.00259	CcSEcCtD
Niacin—QPRT—Disease—SLC11A1—Crohn's disease	0.000161	0.00265	CbGpPWpGaD
Niacin—Paraesthesia—Mesalazine—Crohn's disease	0.000161	0.00257	CcSEcCtD
Niacin—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000161	0.00257	CcSEcCtD
Niacin—Dyspnoea—Mesalazine—Crohn's disease	0.00016	0.00255	CcSEcCtD
Niacin—Somnolence—Mesalazine—Crohn's disease	0.000159	0.00254	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—CCR6—Crohn's disease	0.000158	0.0026	CbGpPWpGaD
Niacin—QPRT—Metabolism—GPX4—Crohn's disease	0.000158	0.0026	CbGpPWpGaD
Niacin—Dyspepsia—Mesalazine—Crohn's disease	0.000158	0.00252	CcSEcCtD
Niacin—SLC16A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000157	0.00258	CbGpPWpGaD
Niacin—NNMT—Metabolism—FADS1—Crohn's disease	0.000157	0.00258	CbGpPWpGaD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000156	0.00257	CbGpPWpGaD
Niacin—Salicylic acid—ALB—Crohn's disease	0.000156	0.471	CrCbGaD
Niacin—Decreased appetite—Mesalazine—Crohn's disease	0.000156	0.00249	CcSEcCtD
Niacin—Body temperature increased—Azathioprine—Crohn's disease	0.000155	0.00248	CcSEcCtD
Niacin—Abdominal pain—Azathioprine—Crohn's disease	0.000155	0.00248	CcSEcCtD
Niacin—HCAR3—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000155	0.00255	CbGpPWpGaD
Niacin—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000155	0.00247	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—RSPO3—Crohn's disease	0.000154	0.00253	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SEL1L—Crohn's disease	0.000154	0.00253	CbGpPWpGaD
Niacin—Erectile dysfunction—Prednisone—Crohn's disease	0.000153	0.00245	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—PTGER4—Crohn's disease	0.000153	0.00252	CbGpPWpGaD
Niacin—Pain—Mesalazine—Crohn's disease	0.000153	0.00245	CcSEcCtD
Niacin—QPRT—Metabolism—GCKR—Crohn's disease	0.000152	0.00251	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—CCR6—Crohn's disease	0.00015	0.00246	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000148	0.00243	CbGpPWpGaD
Niacin—NNMT—Metabolism—GPX4—Crohn's disease	0.000147	0.00241	CbGpPWpGaD
Niacin—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000146	0.00234	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—SEL1L—Crohn's disease	0.000146	0.0024	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—PTGER4—Crohn's disease	0.000145	0.00239	CbGpPWpGaD
Niacin—Hypersensitivity—Azathioprine—Crohn's disease	0.000145	0.00231	CcSEcCtD
Niacin—Urticaria—Mesalazine—Crohn's disease	0.000142	0.00227	CcSEcCtD
Niacin—NNMT—Metabolism—GCKR—Crohn's disease	0.000142	0.00233	CbGpPWpGaD
Niacin—Abdominal pain—Mesalazine—Crohn's disease	0.000142	0.00226	CcSEcCtD
Niacin—Body temperature increased—Mesalazine—Crohn's disease	0.000142	0.00226	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—CCR9—Crohn's disease	0.000141	0.00232	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PTGER4—Crohn's disease	0.000139	0.00229	CbGpPWpGaD
Niacin—SLC16A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000139	0.00228	CbGpPWpGaD
Niacin—QPRT—Disease—RBX1—Crohn's disease	0.000138	0.00227	CbGpPWpGaD
Niacin—QPRT—Disease—HSPA1B—Crohn's disease	0.000138	0.00227	CbGpPWpGaD
Niacin—SLC22A5—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000135	0.00222	CbGpPWpGaD
Niacin—Diarrhoea—Azathioprine—Crohn's disease	0.000134	0.00215	CcSEcCtD
Niacin—Haemoglobin—Prednisone—Crohn's disease	0.000134	0.00214	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—CCR9—Crohn's disease	0.000134	0.0022	CbGpPWpGaD
Niacin—Haemorrhage—Prednisone—Crohn's disease	0.000133	0.00213	CcSEcCtD
Niacin—Hypersensitivity—Mesalazine—Crohn's disease	0.000132	0.00211	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—PTGER4—Crohn's disease	0.000132	0.00217	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—GPR65—Crohn's disease	0.000131	0.00215	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000131	0.00215	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—IL3—Crohn's disease	0.00013	0.00215	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00013	0.00214	CbGpPWpGaD
Niacin—Dizziness—Azathioprine—Crohn's disease	0.00013	0.00208	CcSEcCtD
Niacin—Asthenia—Mesalazine—Crohn's disease	0.000128	0.00205	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000127	0.0021	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000127	0.0021	CbGpPWpGaD
Niacin—Pruritus—Mesalazine—Crohn's disease	0.000127	0.00202	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000126	0.00208	CbGpPWpGaD
Niacin—Vomiting—Azathioprine—Crohn's disease	0.000125	0.002	CcSEcCtD
Niacin—Eye disorder—Prednisone—Crohn's disease	0.000125	0.00199	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—GPR65—Crohn's disease	0.000124	0.00204	CbGpPWpGaD
Niacin—Rash—Azathioprine—Crohn's disease	0.000124	0.00198	CcSEcCtD
Niacin—Dermatitis—Azathioprine—Crohn's disease	0.000124	0.00198	CcSEcCtD
Niacin—Flushing—Prednisone—Crohn's disease	0.000124	0.00198	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—IL3—Crohn's disease	0.000124	0.00203	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000124	0.00203	CbGpPWpGaD
Niacin—Headache—Azathioprine—Crohn's disease	0.000123	0.00197	CcSEcCtD
Niacin—Diarrhoea—Mesalazine—Crohn's disease	0.000122	0.00196	CcSEcCtD
Niacin—Angiopathy—Prednisone—Crohn's disease	0.000121	0.00193	CcSEcCtD
Niacin—QPRT—Disease—UBE2D1—Crohn's disease	0.000121	0.00199	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00012	0.00197	CbGpPWpGaD
Niacin—SLC22A5—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000119	0.00196	CbGpPWpGaD
Niacin—Arrhythmia—Prednisone—Crohn's disease	0.000119	0.0019	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—IL3—Crohn's disease	0.000118	0.00195	CbGpPWpGaD
Niacin—Dizziness—Mesalazine—Crohn's disease	0.000118	0.00189	CcSEcCtD
Niacin—Alopecia—Prednisone—Crohn's disease	0.000118	0.00188	CcSEcCtD
Niacin—Nausea—Azathioprine—Crohn's disease	0.000117	0.00186	CcSEcCtD
Niacin—Erythema—Prednisone—Crohn's disease	0.000116	0.00185	CcSEcCtD
Niacin—Malnutrition—Prednisone—Crohn's disease	0.000116	0.00185	CcSEcCtD
Niacin—SLC16A3—Metabolism—PLA2G4F—Crohn's disease	0.000115	0.0019	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—RASGRP1—Crohn's disease	0.000115	0.00188	CbGpPWpGaD
Niacin—Vomiting—Mesalazine—Crohn's disease	0.000114	0.00182	CcSEcCtD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000113	0.00186	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000113	0.00186	CbGpPWpGaD
Niacin—Rash—Mesalazine—Crohn's disease	0.000113	0.0018	CcSEcCtD
Niacin—Dermatitis—Mesalazine—Crohn's disease	0.000113	0.0018	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—IL3—Crohn's disease	0.000112	0.00185	CbGpPWpGaD
Niacin—Headache—Mesalazine—Crohn's disease	0.000112	0.00179	CcSEcCtD
Niacin—SLC16A3—Hemostasis—ITGA4—Crohn's disease	0.00011	0.00181	CbGpPWpGaD
Niacin—Vision blurred—Prednisone—Crohn's disease	0.000109	0.00175	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—RASGRP1—Crohn's disease	0.000109	0.00179	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—IL3—Crohn's disease	0.000107	0.00176	CbGpPWpGaD
Niacin—Nausea—Mesalazine—Crohn's disease	0.000106	0.0017	CcSEcCtD
Niacin—Angioedema—Prednisone—Crohn's disease	0.000106	0.00169	CcSEcCtD
Niacin—Vertigo—Prednisone—Crohn's disease	0.000104	0.00167	CcSEcCtD
Niacin—Syncope—Prednisone—Crohn's disease	0.000104	0.00166	CcSEcCtD
Niacin—SLC16A3—Hemostasis—RASGRP1—Crohn's disease	0.000104	0.00171	CbGpPWpGaD
Niacin—Loss of consciousness—Prednisone—Crohn's disease	0.000102	0.00163	CcSEcCtD
Niacin—HCAR2—GPCR ligand binding—CXCL8—Crohn's disease	9.92e-05	0.00163	CbGpPWpGaD
Niacin—Myalgia—Prednisone—Crohn's disease	9.88e-05	0.00158	CcSEcCtD
Niacin—Arthralgia—Prednisone—Crohn's disease	9.88e-05	0.00158	CcSEcCtD
Niacin—SLC16A3—Metabolism—MTMR3—Crohn's disease	9.82e-05	0.00162	CbGpPWpGaD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	9.81e-05	0.00157	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	9.74e-05	0.0016	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—F5—Crohn's disease	9.66e-05	0.00159	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—ALB—Crohn's disease	9.63e-05	0.00158	CbGpPWpGaD
Niacin—Anaphylactic shock—Prednisone—Crohn's disease	9.47e-05	0.00151	CcSEcCtD
Niacin—Oedema—Prednisone—Crohn's disease	9.47e-05	0.00151	CcSEcCtD
Niacin—HCAR3—GPCR ligand binding—CXCL8—Crohn's disease	9.41e-05	0.00155	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCR6—Crohn's disease	9.33e-05	0.00154	CbGpPWpGaD
Niacin—Shock—Prednisone—Crohn's disease	9.32e-05	0.00149	CcSEcCtD
Niacin—SLC16A3—SLC-mediated transmembrane transport—ALB—Crohn's disease	9.25e-05	0.00152	CbGpPWpGaD
Niacin—Tachycardia—Prednisone—Crohn's disease	9.24e-05	0.00148	CcSEcCtD
Niacin—Skin disorder—Prednisone—Crohn's disease	9.2e-05	0.00147	CcSEcCtD
Niacin—Hyperhidrosis—Prednisone—Crohn's disease	9.16e-05	0.00146	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—IL2RA—Crohn's disease	9.14e-05	0.0015	CbGpPWpGaD
Niacin—Anorexia—Prednisone—Crohn's disease	9.03e-05	0.00144	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—GCKR—Crohn's disease	8.98e-05	0.00148	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCR6—Crohn's disease	8.85e-05	0.00146	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—IL2RA—Crohn's disease	8.66e-05	0.00142	CbGpPWpGaD
Niacin—QPRT—Disease—SMAD3—Crohn's disease	8.65e-05	0.00142	CbGpPWpGaD
Niacin—Musculoskeletal discomfort—Prednisone—Crohn's disease	8.63e-05	0.00138	CcSEcCtD
Niacin—Insomnia—Prednisone—Crohn's disease	8.57e-05	0.00137	CcSEcCtD
Niacin—Paraesthesia—Prednisone—Crohn's disease	8.5e-05	0.00136	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—RBX1—Crohn's disease	8.44e-05	0.00139	CbGpPWpGaD
Niacin—Dyspepsia—Prednisone—Crohn's disease	8.34e-05	0.00133	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—IL2RA—Crohn's disease	8.3e-05	0.00137	CbGpPWpGaD
Niacin—Decreased appetite—Prednisone—Crohn's disease	8.23e-05	0.00132	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—PTGER4—Crohn's disease	8.22e-05	0.00135	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—RBX1—Crohn's disease	8e-05	0.00132	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	7.98e-05	0.00131	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	7.94e-05	0.00131	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL2RA—Crohn's disease	7.87e-05	0.00129	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PTGER4—Crohn's disease	7.79e-05	0.00128	CbGpPWpGaD
Niacin—Gastrointestinal pain—Prednisone—Crohn's disease	7.74e-05	0.00124	CcSEcCtD
Niacin—SLC16A3—Metabolism—FADS1—Crohn's disease	7.65e-05	0.00126	CbGpPWpGaD
Niacin—Urticaria—Prednisone—Crohn's disease	7.52e-05	0.0012	CcSEcCtD
Niacin—SLC16A3—Hemostasis—IL2RA—Crohn's disease	7.51e-05	0.00124	CbGpPWpGaD
Niacin—Abdominal pain—Prednisone—Crohn's disease	7.49e-05	0.0012	CcSEcCtD
Niacin—Body temperature increased—Prednisone—Crohn's disease	7.49e-05	0.0012	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—UBE2D1—Crohn's disease	7.4e-05	0.00122	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—RIPK2—Crohn's disease	7.18e-05	0.00118	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GPX4—Crohn's disease	7.16e-05	0.00118	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	7.05e-05	0.00116	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—UBE2D1—Crohn's disease	7.02e-05	0.00115	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL3—Crohn's disease	7e-05	0.00115	CbGpPWpGaD
Niacin—Hypersensitivity—Prednisone—Crohn's disease	6.98e-05	0.00111	CcSEcCtD
Niacin—SLC16A3—Metabolism—GCKR—Crohn's disease	6.92e-05	0.00114	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—GCKR—Crohn's disease	6.86e-05	0.00113	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—RIPK2—Crohn's disease	6.8e-05	0.00112	CbGpPWpGaD
Niacin—Asthenia—Prednisone—Crohn's disease	6.8e-05	0.00109	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—RASGRP1—Crohn's disease	6.77e-05	0.00111	CbGpPWpGaD
Niacin—Pruritus—Prednisone—Crohn's disease	6.7e-05	0.00107	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—IL3—Crohn's disease	6.64e-05	0.00109	CbGpPWpGaD
Niacin—Diarrhoea—Prednisone—Crohn's disease	6.48e-05	0.00104	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—RASGRP1—Crohn's disease	6.42e-05	0.00106	CbGpPWpGaD
Niacin—Dizziness—Prednisone—Crohn's disease	6.26e-05	0.001	CcSEcCtD
Niacin—SLC16A1—Metabolism—PLA2G4F—Crohn's disease	6.24e-05	0.00103	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	6.21e-05	0.00102	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—JAK2—Crohn's disease	6.14e-05	0.00101	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SOCS1—Crohn's disease	6.13e-05	0.00101	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.06e-05	0.000997	CbGpPWpGaD
Niacin—Vomiting—Prednisone—Crohn's disease	6.02e-05	0.000962	CcSEcCtD
Niacin—Rash—Prednisone—Crohn's disease	5.97e-05	0.000954	CcSEcCtD
Niacin—Dermatitis—Prednisone—Crohn's disease	5.97e-05	0.000953	CcSEcCtD
Niacin—SLC16A1—Hemostasis—ITGA4—Crohn's disease	5.94e-05	0.000977	CbGpPWpGaD
Niacin—Headache—Prednisone—Crohn's disease	5.93e-05	0.000948	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—TYK2—Crohn's disease	5.85e-05	0.000962	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—JAK2—Crohn's disease	5.82e-05	0.000958	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SOCS1—Crohn's disease	5.81e-05	0.000956	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IL3—Crohn's disease	5.79e-05	0.000952	CbGpPWpGaD
Niacin—QPRT—Disease—TYK2—Crohn's disease	5.64e-05	0.000928	CbGpPWpGaD
Niacin—Nausea—Prednisone—Crohn's disease	5.63e-05	0.000899	CcSEcCtD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—ALB—Crohn's disease	5.62e-05	0.000925	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—CXCL8—Crohn's disease	5.61e-05	0.000922	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—RASGRP1—Crohn's disease	5.6e-05	0.000921	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—JAK2—Crohn's disease	5.58e-05	0.000917	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—TYK2—Crohn's disease	5.54e-05	0.000912	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—ALB—Crohn's disease	5.43e-05	0.000893	CbGpPWpGaD
Niacin—QPRT—Disease—JAK2—Crohn's disease	5.38e-05	0.000885	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—CXCL8—Crohn's disease	5.32e-05	0.000874	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—MTMR3—Crohn's disease	5.3e-05	0.000872	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SMAD3—Crohn's disease	5.3e-05	0.000871	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—JAK2—Crohn's disease	5.29e-05	0.00087	CbGpPWpGaD
Niacin—QPRT—Disease—CD4—Crohn's disease	5.1e-05	0.000839	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—CXCL8—Crohn's disease	5.09e-05	0.000837	CbGpPWpGaD
Niacin—QPRT—Disease—PTGS2—Crohn's disease	5.07e-05	0.000833	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—JAK2—Crohn's disease	5.05e-05	0.00083	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SMAD3—Crohn's disease	5.02e-05	0.000826	CbGpPWpGaD
Niacin—SLC16A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	5e-05	0.000822	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL2RA—Crohn's disease	4.9e-05	0.000806	CbGpPWpGaD
Niacin—QPRT—Metabolism—ALB—Crohn's disease	4.85e-05	0.000798	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—CXCL8—Crohn's disease	4.83e-05	0.000794	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—ALB—Crohn's disease	4.7e-05	0.000773	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL2RA—Crohn's disease	4.65e-05	0.000764	CbGpPWpGaD
Niacin—NNMT—Metabolism—ALB—Crohn's disease	4.51e-05	0.000742	CbGpPWpGaD
Niacin—SLC22A5—SLC-mediated transmembrane transport—ALB—Crohn's disease	4.3e-05	0.000707	CbGpPWpGaD
Niacin—QPRT—Metabolism—PTGS2—Crohn's disease	4.24e-05	0.000698	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—FADS1—Crohn's disease	4.13e-05	0.000679	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IL2RA—Crohn's disease	4.06e-05	0.000667	CbGpPWpGaD
Niacin—QPRT—Disease—STAT3—Crohn's disease	3.95e-05	0.00065	CbGpPWpGaD
Niacin—NNMT—Metabolism—PTGS2—Crohn's disease	3.94e-05	0.000649	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GPX4—Crohn's disease	3.87e-05	0.000636	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GCKR—Crohn's disease	3.74e-05	0.000614	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TYK2—Crohn's disease	3.45e-05	0.000568	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—JAK2—Crohn's disease	3.3e-05	0.000542	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TYK2—Crohn's disease	3.27e-05	0.000539	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—JAK2—Crohn's disease	3.12e-05	0.000514	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CXCL8—Crohn's disease	3.01e-05	0.000495	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—ALB—Crohn's disease	2.93e-05	0.000482	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—IL6—Crohn's disease	2.86e-05	0.00047	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.86e-05	0.00047	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CXCL8—Crohn's disease	2.85e-05	0.000469	CbGpPWpGaD
Niacin—QPRT—Disease—IL6—Crohn's disease	2.76e-05	0.000454	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—JAK2—Crohn's disease	2.73e-05	0.000448	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL6—Crohn's disease	2.71e-05	0.000446	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.54e-05	0.000418	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—STAT3—Crohn's disease	2.42e-05	0.000398	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—STAT3—Crohn's disease	2.29e-05	0.000377	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ALB—Crohn's disease	2.2e-05	0.000362	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ALB—Crohn's disease	2.18e-05	0.000359	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTGS2—Crohn's disease	1.93e-05	0.000317	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	1.74e-05	0.000286	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL6—Crohn's disease	1.69e-05	0.000278	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL6—Crohn's disease	1.6e-05	0.000263	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MTMR3—Crohn's disease	1.48e-05	0.000243	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALB—Crohn's disease	1.19e-05	0.000196	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—FADS1—Crohn's disease	1.15e-05	0.000189	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GPX4—Crohn's disease	1.08e-05	0.000177	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GCKR—Crohn's disease	1.04e-05	0.000171	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTGS2—Crohn's disease	1.04e-05	0.000171	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALB—Crohn's disease	3.31e-06	5.45e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTGS2—Crohn's disease	2.9e-06	4.77e-05	CbGpPWpGaD
